Sarepta Therapeutics Inc (SRPT) — Free Cash Flow Generation Index

Latest as of December 2025: 0.96x

Sarepta Therapeutics Inc (SRPT) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of $125.38 Million represents 1% of operating cash flow ($131.21 Million). Explore Sarepta Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$125.38 Million
USD

Operating Cash Flow

$131.21 Million
USD

Capital Expenditures

$5.83 Million
USD

Sarepta Therapeutics Inc Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Sarepta Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see SRPT cash flow metrics.

Annual Free Cash Flow Generation for Sarepta Therapeutics Inc (2020–2020)

Year-by-year Free Cash Flow Generation Index for Sarepta Therapeutics Inc. Check Sarepta Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.24x $25.26 Million $107.47 Million $82.20 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).